BioCentury | Feb 16, 2015
Company News

CytoSorbents, Aferetica deal

...CytoSorbents granted Aferetica exclusive, Italian distribution rights to CytoSorb cytokine reduction therapy for critical care applications...
...for indications in which cytokines are elevated, including sepsis and other inflammatory conditions. CytoSorbents said Aferetica...
...further financial details. Aferetica did not respond to questions. CytoSorbents Corp. (NASDAQ:CTSO), Monmouth Junction, N.J. Aferetica s.r.l....
Items per page:
1 - 1 of 1
BioCentury | Feb 16, 2015
Company News

CytoSorbents, Aferetica deal

...CytoSorbents granted Aferetica exclusive, Italian distribution rights to CytoSorb cytokine reduction therapy for critical care applications...
...for indications in which cytokines are elevated, including sepsis and other inflammatory conditions. CytoSorbents said Aferetica...
...further financial details. Aferetica did not respond to questions. CytoSorbents Corp. (NASDAQ:CTSO), Monmouth Junction, N.J. Aferetica s.r.l....
Items per page:
1 - 1 of 1